Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
2-(5,7-Dimethyl-3-Methylsulfanyl-1-Benzofuran-2-Yl)acetic Acid
Acta Crystallographica Section E Structure Reports Online
2-(3-Methylsulfanyl-5-Propyl-1-Benzofuran-2-Yl)acetic Acid
Acta Crystallographica Section E Structure Reports Online
Free Fatty Acid Receptor 2 (GPR43; FFAR2)
Science-Business eXchange
2-(6-Benzoyl-2-Oxo-1,3-Benzothiazol-3-Yl)acetic Acid
Acta Crystallographica Section E Structure Reports Online
2-Methyl-3-(3-Methylphenyl)acrylic Acid
Acta Crystallographica Section E Structure Reports Online
2-(5-Fluoro-3-Methylsulfanyl-1-Benzofuran-2-Yl)acetic Acid
Acta Crystallographica Section E Structure Reports Online
Serum Uric Acid in Type 2 Diabetics
Annals of the College of Medicine, Mosul
Multiparameter Lead Optimization to Give an Oral Checkpoint Kinase 1 (CHK1) Inhibitor Clinical Candidate: (R)5-((4-((Morpholin-2-Ylmethyl)amino)-5-(Trifluoromethyl)pyridin-2-Yl)amino)pyrazine-2-Carbonitrile (CCT245737)
2-Hydroxypyridine T 2-Pyridone Tautomerization: Catalytic Influence of Formic Acid
1-[3-(2-Benzyloxy-6-Hydroxy-4-Methylphenyl)-5-[3,5-Bis(trifluoromethyl)phenyl]-4,5-Dihydro-1h-Pyrazol-1-Yl]propane-1-One
Acta Crystallographica Section E Structure Reports Online
‹
18
19
20
21
22
23
24
›
